Literature DB >> 25591809

Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice.

Z Xu1, Y Dong2, F Peng3, Z Yu4, Y Zuo4, Z Dai5, Y Chen6, J Wang6, X Hu3, Q Zhou3, H Ma6, Y Bao3, G Gao5, M Chen3.   

Abstract

This study aimed to explore the potential therapeutic effects of the combination of pigment epithelium-derived factor (PEDF) and radiation on lung cancer. The Lewis lung cancer (LLC) allografts in nude mice were treated with radiation, PEDF and PEDF combined with radiation. The morphologic changes of tumor vasculature and the hypoxic fraction of tumor tissues were evaluated. Significant inhibition of tumor growth was observed when radiation was applied between the 3rd and 7th day (the vasculature normalization window) after the initiation of PEDF treatment. During the vasculature normalization window, the tumor blood vessels in PEDF-treated mice were less tortuous and more uniform than those in the LLC allograft tumor treated with phosphate-buffered saline. Meanwhile, the thickness of the basement membrane was remarkably reduced and pericyte coverage was significantly increased with the PEDF treatment. We also found that tumor hypoxic fraction decreased during the 3rd to the 7th day after PEDF treatment, suggesting improved intratumoral oxygenation. Taken together, our results show that PEDF improved the effects of radiation therapy on LLC allografts by inducing a vascular normalization window from the 3rd to the 7th day after PEDF treatment. Our findings provide a basis for treating lung cancer with the combination of PEDF and radiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25591809     DOI: 10.1038/cgt.2014.79

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  36 in total

1.  Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.

Authors:  Na Li; Dawei Zheng; Xiyin Wei; Ziliang Jin; Cuicui Zhang; Kai Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

2.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor.

Authors:  Lin Wang; Volker Schmitz; Alberto Perez-Mediavilla; Iñigo Izal; Jesus Prieto; Cheng Qian
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

6.  Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family.

Authors:  F R Steele; G J Chader; L V Johnson; J Tombran-Tink
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  Pigment epithelium-derived factor is a niche signal for neural stem cell renewal.

Authors:  Carmen Ramírez-Castillejo; Francisco Sánchez-Sánchez; Celia Andreu-Agulló; Sacri R Ferrón; J Daniel Aroca-Aguilar; Pilar Sánchez; Helena Mira; Julio Escribano; Isabel Fariñas
Journal:  Nat Neurosci       Date:  2006-02-19       Impact factor: 24.884

8.  Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.

Authors:  M L Broadhead; C R Dass; P F M Choong
Journal:  Br J Cancer       Date:  2011-10-06       Impact factor: 7.640

Review 9.  Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.

Authors:  Vijay Chandolu; Crispin R Dass
Journal:  J Biomed Biotechnol       Date:  2012-05-28

10.  Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.

Authors:  Fang Peng; Zumin Xu; Jin Wang; Yuanyuan Chen; Qiang Li; Yufang Zuo; Jing Chen; Xiao Hu; Qichao Zhou; Yan Wang; Honglian Ma; Yong Bao; Ming Chen
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

View more
  2 in total

1.  Tumor radiosensitization by gene therapy against endoglin.

Authors:  M Stimac; U Kamensek; M Cemazar; S Kranjc; A Coer; G Sersa
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

Review 2.  Toward Normalization of the Tumor Microenvironment for Cancer Therapy.

Authors:  Jie Zheng; Peng Gao
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.